- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07727850
Change-of-Direction Repeated Sprints in Adolescent Female Basketball Players
Effects of Changes of Direction on Repeated-Sprint Performance, Perceived Exertion, and Acute Cardiovascular Responses in Adolescent Female Basketball Players: A Randomized Crossover Study
Study Overview
Status
Conditions
Detailed Description
This was an acute, randomized, counterbalanced, three-condition crossover study in which each participant completed all experimental conditions and served as her own control.
Following a standardized warm-up, participants completed one of three repeated-sprint protocols during each experimental condition: 10 × 15-m linear sprints without a change of direction, 10 × 15-m sprints incorporating one 180-degree change of direction, or 10 × 15-m sprints incorporating two 180-degree changes of direction. A 30-second passive recovery period was provided between repetitions. Total sprint distance, number of repetitions, and recovery duration were standardized across the three conditions; only the number of changes of direction differed.
Sprint times were recorded using electronic timing gates. Best, average, and worst sprint times were determined, and sprint decrement and the change from best to worst performance were calculated. Rating of perceived exertion was recorded after each protocol. Heart rate, peripheral oxygen saturation, and systolic and diastolic blood pressure were assessed immediately before and after each condition.
The experimental conditions were compared to determine whether increasing the number of 180-degree changes of direction altered absolute repeated-sprint performance, performance maintenance, perceived exertion, or immediate cardiovascular responses.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pamukkale
-
Denizli, Pamukkale, Turkey (Türkiye), 20000
- Pamukkale University Sports Sciences and Technology Research and Application Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female basketball players aged 16-18 years.
- Currently competing in the U16 or U18 basketball leagues in Denizli, Türkiye.
- At least two years of structured basketball training experience.
- Regular participation in at least three training sessions and one official match per week.
- No injury or illness that could prevent maximal sprint performance.
Exclusion Criteria:
- Reporting an injury before testing that could prevent maximal sprint performance.
- Failure to attend all testing sessions or complete all three experimental conditions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sequence 1: Linear-One-COD-Two-COD
Participants assigned to Sequence 1 completed the linear repeated-sprint condition during the first experimental session, the one-COD condition during the second session, and the two-COD condition during the third session.
Consecutive sessions were separated by at least 48 hours.
|
Following a standardized 20-minute dynamic warm-up, participants performed 10 maximal 15-m linear sprints without a change of direction.
Each sprint began from a standing position 0.5 m behind the starting line and was recorded using electronic timing gates.
A 30-second passive recovery period was provided between repetitions, during which participants remained standing.
Following a standardized 20-minute dynamic warm-up, participants performed 10 maximal 15-m repeated sprints.
Each repetition consisted of 7.5 m of forward sprinting followed by one 180-degree change of direction and a 7.5-m return sprint.
Each sprint began from a standing position 0.5 m behind the starting line and was recorded using electronic timing gates.
A 30-second passive recovery period was provided between repetitions, during which participants remained standing.
Following a standardized 20-minute dynamic warm-up, participants performed 10 maximal 15-m repeated sprints.
Each repetition consisted of three consecutive 5-m sections and incorporated two 180-degree changes of direction.
Each sprint began from a standing position 0.5 m behind the starting line and was recorded using electronic timing gates.
A 30-second passive recovery period was provided between repetitions, during which participants remained standing.
|
|
Experimental: Sequence 2: One-COD-Two-COD-Linear
Participants assigned to Sequence 2 completed the one-COD repeated-sprint condition during the first experimental session, the two-COD condition during the second session, and the linear condition during the third session.
Consecutive sessions were separated by at least 48 hours.
|
Following a standardized 20-minute dynamic warm-up, participants performed 10 maximal 15-m linear sprints without a change of direction.
Each sprint began from a standing position 0.5 m behind the starting line and was recorded using electronic timing gates.
A 30-second passive recovery period was provided between repetitions, during which participants remained standing.
Following a standardized 20-minute dynamic warm-up, participants performed 10 maximal 15-m repeated sprints.
Each repetition consisted of 7.5 m of forward sprinting followed by one 180-degree change of direction and a 7.5-m return sprint.
Each sprint began from a standing position 0.5 m behind the starting line and was recorded using electronic timing gates.
A 30-second passive recovery period was provided between repetitions, during which participants remained standing.
Following a standardized 20-minute dynamic warm-up, participants performed 10 maximal 15-m repeated sprints.
Each repetition consisted of three consecutive 5-m sections and incorporated two 180-degree changes of direction.
Each sprint began from a standing position 0.5 m behind the starting line and was recorded using electronic timing gates.
A 30-second passive recovery period was provided between repetitions, during which participants remained standing.
|
|
Experimental: Sequence 3: Two-COD-Linear-One-COD
Participants assigned to Sequence 3 completed the two-COD repeated-sprint condition during the first experimental session, the linear condition during the second session, and the one-COD condition during the third session.
Consecutive sessions were separated by at least 48 hours.
|
Following a standardized 20-minute dynamic warm-up, participants performed 10 maximal 15-m linear sprints without a change of direction.
Each sprint began from a standing position 0.5 m behind the starting line and was recorded using electronic timing gates.
A 30-second passive recovery period was provided between repetitions, during which participants remained standing.
Following a standardized 20-minute dynamic warm-up, participants performed 10 maximal 15-m repeated sprints.
Each repetition consisted of 7.5 m of forward sprinting followed by one 180-degree change of direction and a 7.5-m return sprint.
Each sprint began from a standing position 0.5 m behind the starting line and was recorded using electronic timing gates.
A 30-second passive recovery period was provided between repetitions, during which participants remained standing.
Following a standardized 20-minute dynamic warm-up, participants performed 10 maximal 15-m repeated sprints.
Each repetition consisted of three consecutive 5-m sections and incorporated two 180-degree changes of direction.
Each sprint began from a standing position 0.5 m behind the starting line and was recorded using electronic timing gates.
A 30-second passive recovery period was provided between repetitions, during which participants remained standing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average Sprint Time
Time Frame: Throughout the 10-sprint protocol in each of the three experimental sessions, approximately 5 minutes per condition.
|
The mean completion time of the 10 maximal 15-m sprint repetitions, recorded using Witty electronic timing gates and expressed in seconds.
The outcome was calculated separately for the linear, one-COD, and two-COD repeated-sprint conditions.
|
Throughout the 10-sprint protocol in each of the three experimental sessions, approximately 5 minutes per condition.
|
|
Best Sprint Time
Time Frame: During the 10-sprint protocol in each experimental session, approximately 5 minutes per condition.
|
The fastest completion time (lowest value) among the 10 maximal 15-m sprint repetitions, recorded using Witty electronic timing gates and expressed in seconds.
The outcome was determined separately for the linear, one-COD, and two-COD repeated-sprint conditions.
|
During the 10-sprint protocol in each experimental session, approximately 5 minutes per condition.
|
|
Worst Sprint Time
Time Frame: During the 10-sprint protocol in each experimental session, approximately 5 minutes per condition.
|
The slowest completion time (highest value) among the 10 maximal 15-m sprint repetitions, recorded using Witty electronic timing gates and expressed in seconds.
The outcome was determined separately for the linear, one-COD, and two-COD repeated-sprint conditions.
|
During the 10-sprint protocol in each experimental session, approximately 5 minutes per condition.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sprint Decrement
Time Frame: Calculated from the 10 sprint times recorded during each experimental session, approximately 5 minutes per condition.
|
The percentage reduction in performance across the 10 maximal sprint repetitions.
Sprint decrement was calculated separately for each experimental condition using the following formula: Sdec (%) = ([sum of the 10 sprint times / (best sprint time × 10)] - 1) × 100.
Higher values indicate a greater decline in repeated-sprint performance.
|
Calculated from the 10 sprint times recorded during each experimental session, approximately 5 minutes per condition.
|
|
Worst-to-Best Decrement
Time Frame: Calculated from the best and worst sprint times recorded during each experimental session, approximately 5 minutes per condition.
|
The percentage difference between the fastest and slowest sprint repetitions, calculated separately for each experimental condition using the following formula: [(worst sprint time - best sprint time) / best sprint time] × 100.
Higher values indicate a greater decline from the best to the worst performance.
|
Calculated from the best and worst sprint times recorded during each experimental session, approximately 5 minutes per condition.
|
|
Rating of Perceived Exertion
Time Frame: Immediately after the post-exercise cardiovascular measurements following each of the three experimental conditions.
|
Perceived exertion was assessed using the Borg category-ratio scale ranging from 0 to 10, where 0 represents rest and 10 represents maximal exertion.
Participants rated the overall difficulty of each completed repeated-sprint condition.
|
Immediately after the post-exercise cardiovascular measurements following each of the three experimental conditions.
|
|
Heart Rate
Time Frame: Immediately before and immediately after each of the three experimental conditions.
|
Heart rate was measured using a Soulfix fingertip pulse oximeter placed on the index finger of the left hand.
Values were recorded in beats per minute before and immediately after each repeated-sprint condition.
|
Immediately before and immediately after each of the three experimental conditions.
|
|
Peripheral Oxygen Saturation
Time Frame: Immediately before and immediately after each of the three experimental conditions.
|
Peripheral oxygen saturation (SpO2) was measured using a Soulfix fingertip pulse oximeter placed on the index finger of the left hand.
Values were recorded as a percentage before and immediately after each repeated-sprint condition.
|
Immediately before and immediately after each of the three experimental conditions.
|
|
Systolic Blood Pressure
Time Frame: Immediately before and immediately after each of the three experimental conditions.
|
Systolic blood pressure was measured on the left upper arm using an Omron M2 Essential automated digital blood-pressure monitor.
Values were recorded in millimeters of mercury (mmHg) before and immediately after each repeated-sprint condition.
|
Immediately before and immediately after each of the three experimental conditions.
|
|
Diastolic Blood Pressure
Time Frame: Immediately before and immediately after each of the three experimental conditions.
|
Diastolic blood pressure was measured on the left upper arm using an Omron M2 Essential automated digital blood-pressure monitor.
Values were recorded in millimeters of mercury (mmHg) before and immediately after each repeated-sprint condition.
|
Immediately before and immediately after each of the three experimental conditions.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Engin Güneş Atabaş, PhD, Pamukkale Üniversitesi
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PAU-COD-RSA-2026-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Athletic Performance
-
Coşkun YILMAZCompletedAthletic Performance | Neuromuscular Adaptations | Athletic Performance EnhancementTurkey (Türkiye)
-
Federal University of VicosaUniversidad de AntioquiaCompletedAthletic Performance | Exercise PerformanceColombia
-
Shanghai University of SportRecruitingAthletic Performance | Physical PerformanceChina
-
Federal University of VicosaCompletedAthletic Performance | Sprint Performance | YouthsColombia
-
Federal University of VicosaCompletedSprint Performance | Futsal | Jump Performance | Athletic Performance EnhancementColombia
-
University of ThessalyNot yet recruiting
-
University of AarhusInnovation Fund DenmarkRecruitingAthletic PerformanceDenmark
-
Serdar BayrakdaroğluCompleted
-
University of the Incarnate WordCompletedAthletic PerformanceUnited States
-
University of LiegeCompleted
Clinical Trials on Linear Repeated-Sprint Protocol
-
Cairo UniversityCompleted
-
Faculdade de Motricidade HumanaCentro de Alto Rendimento do JamorNot yet recruitingHypoventilation | Normoxia | Normobaric HypoxiaPortugal
-
Faculdade de Motricidade HumanaUniversity of Sao Paulo; Coordenação de Aperfeiçoamento de Pessoal de Nível...RecruitingHypoventilation | Normoxia | Normobaric HypoxiaPortugal
-
Hvidovre University HospitalCompletedHamstring Injury | Sprint PerformanceDenmark
-
Hillel Yaffe Medical CenterUnknown
-
Karolinska InstitutetCompletedMetabolism in Adipose TissueSweden
-
Inonu UniversityCompletedSprint Performance | Agility | Explosive PowerTurkey (Türkiye)
-
Nanyang Technological UniversityKK Women's and Children's Hospital; Institute for Human Development and Potential... and other collaboratorsNot yet recruitingPremature Birth | Autism Spectrum Disorder | Attention-Deficit/Hyperactivity Disorder (ADHD) | Global Developmental DelaySingapore
-
Universitaet InnsbruckUniversity of Erlangen-NürnbergCompletedAnterior Cruciate Ligament InjuriesAustria
-
Uludag UniversityInonu University; Princess Nourah Bint Abdulrahman UniversityCompletedFatigue | Sleep Deprivation | Athletic PerformanceTurkey (Türkiye)